majestic biopharma · est. 2019 · new cairo, egypt
Developing innovative, science-backed pharmaceutical and cosmeceutical solutions for unmet needs.
majestic Biopharma is a forward-thinking pharmaceutical institution dedicated to developing innovative, science-backed healthcare solutions. With a strong presence across local and international markets, we focus on addressing unmet needs through a customer-centric approach.
Driven by quality, innovation, and evidence-based practices, we deliver modern pharmaceutical and cosmeceutical solutions that enhance health and improve quality of life.
We go beyond conventional healthcare — committed to making effective, accessible solutions that create a meaningful impact in people's everyday lives.
To transform scientific innovation into accessible, high-quality healthcare solutions through advanced research, robust product development, and a deep understanding of evolving patient needs.
We build trust in locally developed brands by delivering reliable, evidence-based products that improve both physical and overall well-being.
To become a trusted leader in modern healthcare — advancing global standards and widening access to science-backed pharmaceutical and cosmeceutical solutions that help people live healthier, more confident lives.
2019
majestic Biopharma began its journey with its first product, Bestrilliant — the starting point of a unified vision shared by experienced physicians, pharmacists, and business leaders. What started as a single product initiative soon evolved into a broader mission to build a specialized pharmaceutical and cosmeceutical company.
2020
Built on a cohesive vision, shared values, and a clear sense of purpose, majestic expanded its portfolio by introducing two new brands, Movelex and Femi9, strengthening its presence in both pharmaceutical and cosmeceutical solutions.
2021
majestic continued its expansion and portfolio diversification, launching two additional flagship brands, Capixy and Vacation, alongside its growing portfolio including Movelex, Femi9, and Egatone.
2022
A year of building. With several science-backed solutions advancing through development, majestic deepened its R&D pipeline — continually shaping the future of healthcare and raising standards with each new advancement.
2023
majestic Biopharma expanded its presence and built a new chapter of success in Dubai, UAE — strengthening its regional footprint. As part of this expansion, the company introduced Soralone.
2024
A strategic expansion into the European Union brought high-quality healthcare solutions to a wider audience. As part of this milestone, majestic introduced Pirlome and Methytral.
2025
A new phase of global growth: over 3 new brands and more than 30 new SKUs, expansion into selective markets, and next-generation healthcare innovations — including the launch of Pregnastep. Regional presence strengthened through key partnerships and major events across Egypt and the Middle East.
